AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
216.49
-4.74 (-2.14%)
At close: Jun 18, 2026, 4:00 PM EDT
216.98
+0.49 (0.23%)
After-hours: Jun 18, 2026, 7:59 PM EDT

AbbVie Stock Forecast

Stock Price Forecast

According to 32 analysts polled by S&P Global, AbbVie stock has a consensus rating of "Buy" and an average price target of $253.55. The average 1-year stock price forecast is 17.12% higher than the current stock price, while the lowest is $184 (-15.01%) and the highest is $328 (+51.51%).

Price Target: $253.55 (+17.12%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$184$253.55$258$328
Change-15.01%+17.12%+19.17%+51.51%

Analyst Ratings

The average analyst rating for AbbVie stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy131314161616
Buy688888
Hold999888
Sell110000
Strong Sell000000
Total293131323232

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Bernstein
Bernstein
Hold
Maintains
n/a
HoldMaintainsn/an/aJun 10, 2026
Wells Fargo
Wells Fargo
Buy
Maintains
$260
BuyMaintains$260+20.10%Jun 5, 2026
Bank of America Securities
Bank of America Securities
Buy
Maintains
n/a
BuyMaintainsn/an/aJun 3, 2026
Piper Sandler
Piper Sandler
Buy
Reiterates
$298
BuyReiterates$298+37.65%Jun 1, 2026
Morgan Stanley
Morgan Stanley
Buy
Maintains
$278
BuyMaintains$278+28.41%Jun 1, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
67.23B
from 61.16B
Increased by 9.93%
Revenue Next Year
72.71B
from 67.23B
Increased by 8.15%
EPS This Year
14.24
from 10.00
Increased by 42.42%
EPS Next Year
16.25
from 14.24
Increased by 14.07%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
56.20B58.05B54.32B56.33B61.16B67.23B
Revenue Growth
22.69%3.30%-6.44%3.71%8.57%9.93%
Gross Profit
38.88B41.53B37.49B39.65B43.80B56.53B
Gross Margin
69.19%71.53%69.02%70.37%71.62%84.08%
Operating Income
19.76B20.23B18.21B17.42B21.12B32.01B
Net Income
11.54B11.84B4.86B4.28B4.23B14.85B
EPS
----10.0014.24
EPS Growth
-----1.19%42.42%
Forward PE
10.0412.7213.9614.8116.5715.20
Dividend / Share
5.315.715.996.296.656.86
Dividend Growth
-7.53%4.90%5.01%5.72%3.22%
Free Cash Flow
19.39B21.26B22.97B19.41B18.34B27.47B
No. Analysts
-----29
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High67.7B
Avg67.2B
Low65.6B

Revenue Growth

Revenue Growth202620272028
High
10.7%
Avg
9.9%
Low
7.3%

EPS Forecast

EPS202620272028
High14.81
Avg14.24
Low13.89

EPS Growth

EPS Growth202620272028
High
48.1%
Avg
42.4%
Low
38.9%